Table 1. Summary of clinical, laboratory, and imaging characteristics, as well as information about the need for oxygen therapy.
| Han et al. 12 | Xia et al. 13 | Zhu et al. 21 | Qiu et al. 22 | Zheng et al. 23 | Lu et al. 24 | |
|---|---|---|---|---|---|---|
| Number of children | 7 | 20 | 10 | 36 | 25 | 171 |
| Age group (years) | 0-13 | 0-14 | 1-18 | 1-16 | 0-14 | 0-15 |
| Male/female | 4/3 | 13/7 | 5/5 | 23/13 | 14/11 | 104/67 |
| Location | China | China | China | China | China | China |
| Period |
|
|
|
|
February |
|
| Fever | 5 (71.4%) | 12 (60%) | 4 (40%) | 13 (36.1%) | 13 (52%) | 71 (41.5%) |
| Cough | 5 (71.4%) | 13 (65%) | 3 (30%) | 7 (19.4%) | 11 (44%) | 83 (48.5%) |
| Myalgia/fatigue | 0 | 1 (5%) | --- | --- | --- | 13 (7.6%) |
| Diarrhea, nausea, and/or vomiting | 4 (57.1%) | 3 (15%) | 0 | --- | 3 (12%) | 15 (8.8%) |
| Odynophagia | 1 (14.3%) | 1 (5%) | 0 | --- | --- | --- |
| Dyspnea/ tachypnea | 3 (42.9%) | 2 (10%) | 0 | 1 (2.8%) | 2 (8%) | 49 (28.7%) |
| Abnormality on chest CT | 5 (71.4%) | 16 (80%) | 5 (50%) | 19 (52.8%) | 17 (68%) | 111 (64.9%) |
| Leukocytosis | 2 (28.6%) | 2 (10%) | --- | --- | --- | --- |
| Neutropenia | 1 (14.3%) | --- | --- | --- | --- | --- |
| Lymphocytosis | --- | 3 (15%) | --- | --- | --- | --- |
| Lymphopenia | --- | 7 (35%) | 0 | 11 (30.6%) | 10 (40%) | 6 (3.5%) |
| Leukopenia | --- | 4 (20%) | 0 | 7 (19.4%) | --- | --- |
| Increased AST and ALT | 2 (28.6%) | 5 (25%) | 3 (30%) | 2 (5.6%) | --- | --- |
| Increased CK/CK-MB | 4 (57.1%) | 15 (75%) | --- | 11 (30.6%) | --- | --- |
| Increased CRP | 2 (28.6%) | 16 (80%) | 0 | 1 (2.8%) | --- | --- |
| Increased procalcitonin | 3 (42.9%) | 16 (80%) | 0 | 6 (16.7%) | --- | --- |
| Increased ESR | 3 (42.9%) | --- | --- | --- | --- | --- |
| Need for oxygen | 2 (28.6%) | --- | 1 (10%) | 6 (16.7%) | 2 (8%) | 4 (2.3%) |
CT: computed tomography; AST: aspartate transaminase; ALT: alanine transaminase; CK: creatine kinase: CK-MB: CK MB isoenzyme; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate.